New Grants will Accelerate Clinical Trials in Rare Neurological Disorders
Two new grants from the National Institute of Neurological Disorders and Stroke (NINDS) will pave the way for new treatments for neuronal ceroid lipofuscinoses and Charcot Marie Tooth diseases, two groups of rare neurological disorders. The funding, which totals $10 million, will support new research programs led by University of Rochester Medical Center (URMC) neurologists Erika Augustine, M.D., and David Herrmann, M.B.B.Ch., and involve an international team of scientists and clinicians.
Source: University of Rochester Medical Center Press Releases - Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news
More News: Brain | Charcot-Marie-Tooth Disease | Clinical Trials | Funding | Grants | Neurology | Stroke | Universities & Medical Training